Inventor · disambiguated record
Takeo Ishiyama
Also filed as: ISHIYAMA TAKEO
7 granted patents·5 pending applications·9 citations·filing 2004–2021
79Inventor score
Files withSUMITOMO DAINIPPON PHARMA CO LTD4OHNO YUKIHIRO3IKEDA KAZUHITO2ISHIYAMA TAKEO2SUMITOMO PHARMA CO LTD1
Top patents by PatentIndex Score
12 records- 0178US8258139B2Method of treatment for mental disordersIKEDA KAZUHITO·Filed 2011·Granted Sep 4, 2012·4 cites·5 claims
- 0275US8835438B2Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidoneISHIYAMA TAKEO·Filed 2009·Granted Sep 16, 2014·4 cites·3 claims
- 0368US8148379B2Therapeutic agent for senile dementiaOHNO YUKIHIRO·Filed 2008·Granted Apr 3, 2012·1 cites·4 claims
- 0461US2019022091A1Method of treatment for mental disordersSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 0558US10098875B2Method of treatment for mental disordersSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Oct 16, 2018·0 cites·8 claims
- 0658US9827242B2Method of treatment for mental disordersSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Nov 28, 2017·0 cites·6 claims
- 0757US9259423B2Method of treatment for mental disordersIKEDA KAZUHITO·Filed 2012·Granted Feb 16, 2016·0 cites·3 claims
- 0855US2014356292A1In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophreniaSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2014·Application pending·0 cites
- 0953US2023109839A1Therapeutic agent for tauopathiesSUMITOMO PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1050US8552000B2Therapeutic agent for senile dementiaOHNO YUKIHIRO·Filed 2012·Granted Oct 8, 2013·0 cites·11 claims
- 1149US2006142276A1Therapeutic agent for senile dementiaOHNO YUKIHIRO·Filed 2004·Application pending·0 cites
- 1245US2007160537A1In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophreniaISHIYAMA TAKEO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takeo Ishiyama files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →